Abstracts - faqs.org

Abstracts

Biological sciences

Search abstracts:
Abstracts » Biological sciences

PML is induced by oncogenic ras and promotes premature senescence

Article Abstract:

Promyelocytic leukemia (PML), which promotes premature aging, is brought on by oncogenic ras. Gene expression patterns have been compared to look at ras-arrested vs quiescent IMR90 fibroblasts. A gene up-regulated in ras-induced arrest was PML protein. It is a potential tumor suppressor and encodes a component of nuclear structure, promyelocytic oncogenic domains. Results show that PML acts with Rb and p53 to promote ras-induced senescence.

Author: Lowe, Scott W., Prives, Carol, Ferbeyre, Gerardo, De Stanchina, Elisa, Querido, Emmanuelle, Baptiste, Nicole
Publisher: Cold Spring Harbor Laboratory Press
Publication Name: Genes & Development
Subject: Biological sciences
ISSN: 0890-9369
Year: 2000
United States, Statistical Data Included, Physiological aspects, Cytochemistry, Fibroblasts, Ras genes, Old age

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Dissecting eIF4E action in tumorigenesis

Article Abstract:

A study is presented to show that the ocogenic activity of eIF4E correlates with its ability to activate translation and become phosphorylated on Ser 209. The results show how eIF4E contributes to tumorigenesis and how it is suitable for therapeutic intervention.

Author: Zhu Hong, Lowe, Scott W., Pelletier, Jerry, Mills, John R., Watanabe-Fukunaga, Rie, Teruya-Feldstein, Julie, Wendel, Hans-Guido, Malina, Abba, Silva, Ricardo L.A., Ueda, Takeshi, Fukunaga, Rikiro
Publisher: Cold Spring Harbor Laboratory Press
Publication Name: Genes & Development
Subject: Biological sciences
ISSN: 0890-9369
Year: 2007
Science & research, Phosphorylation, Genetic translation, Translation (Genetics), Apoptosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


E1A signaling to p53 involves the p19ARF tumor suppressor

Article Abstract:

Via a signaling pathway that involves the tumor suppressor p19ARF and retinoblastoma protein, the adenovirus E1A oncogene activates p53. It can be seen that p19 is part of a p53-dependent failsafe system to stop rampant cell proliferation. There are synergistic effects for p19ARF and DNA damage pathways in inducing p53 and they may help E1A's contribution to chemo- and radiosensitivity.

Author: McCurrach, Mila E., Lowe, Scott W., Shieh, Sheau-Yann, Prives, Carol, Roussel, Martine F., Sherr, Charles J., Ferbeyre, Gerardo, De Stanchina, Elisa, Zindy, Frederique, Samuelson, Andrew V.
Publisher: Cold Spring Harbor Laboratory Press
Publication Name: Genes & Development
Subject: Biological sciences
ISSN: 0890-9369
Year: 1998
DNA damage, Tumor suppressor genes, Cell proliferation, Adenoviruses

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Genetic aspects, Oncogenes, Retinoblastoma
Similar abstracts:
  • Abstracts: Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling
  • Abstracts: The viable-but-nonculturable state induced by abiotic stress in the biocontrol agent Pseudomonas fluorescens CHA0 does not promote strain persistence in soil
  • Abstracts: Analysis of the Bradyrhizobium japonicum hemH gene and its expression in Escherichia coli. Fur-independent regulatin of iron metabolism by Irr in Bradyrhizobium japonicum
  • Abstracts: Evolutionary interactions between Drosophila melanogaster and its parasitoid Asobara tabida. Genetics of alpha-amanitin resistance in a natural population of Drosophila melanogaster
  • Abstracts: ACF consists of two subunits, Acf1 and ISWI, that function cooperatively in the ATP-dependent catalysis of chromatin assembly
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.